Table 1 Baseline characteristics of study participants
Variable | 1:1 (n = 19) | Group-Supervised (n = 16) | Home-Based (N = 18) | P-value | |
|---|---|---|---|---|---|
Age (years), mean (SD) | 69.2 (7.3) | 71.5 (7.2) | 69.6 (8.1) | 0.59 | |
Education, post-secondary, n (%) | 14 (73.7) | 15 (93.8) | 11 (61.1) | 0.085 | |
Race, White, n (%) | 12 (63.2) | 14 (87.5) | 12 (66.7) | 0.59 | |
Marital Status, married (%) | 13 (68.4) | 14 (87.5) | 10 (55.6) | 0.63 | |
Working Status, retired (%) | 11 (57.9) | 9 (56.3) | 13 (72.2) | 0.44 | |
Smoking Status, never smoked (%) | 6 (31.6) | 8 (50.0) | 7 (38.9) | 0.52 | |
ECOG Performance Status, 0–1(%) Missing | 17 (100.0) | 15 (100.0) | 14 (92.7) | 0.64 | |
2 | 1 | 3 | |||
Karnofsky Score, mean % (SD) | 81 (11.1) | 87 (9.9) | 79 (9.2) | 0.082 | |
PSA at diagnosis, ng/mL, median (IQR) | 9 (7–20) | 10 (8–17) | 15 (6–35) | 0.34 | |
Charlson Comorbidity score, n (%) | 0 | 11 (57.9) | 13 (81.3) | 15 (83.3) | 0.23 |
1 | 6 (31.6) | 3 (18.7) | 0 | ||
≥2 | 1 (5.3) | 0 | 1 (5.5) | ||
Missing | 1 (5.3) | 0 | 2 (11.0) | ||
Clinical Stage, n (%) | T1-T2 | 9 (56.3) | 9 (60.0) | 9 (52.9) | 0.99 |
T3+ | 6 (37.5) | 5 (33.3) | 7 (41.2) | ||
Missing | 4 | 2 | 2 | ||
Gleason score, n (%) | 6 | 3 (21.4) | 1 (6.7) | 1 (5.9) | 0.18 |
7 | 4 (28.6) | 4 (26.7) | 10 (58.8) | ||
8–10 | 7 (50.0) | 10 (66.7) | 6 (35.3) | ||
Missing | 5 | 1 | 1 | ||
Duration of ADT, n (%) | < 3 mo. | 5 (26.3) | 2 (16.7) | 6 (33.3) | 0.59 |
≥3 mo. | 14 (73.7) | 10 (83.3) | 12 (66.7) | ||
Missing | 0 | 4 | 0 | ||
Indication for ADT, n (%) | Adjuvant | 10 (52.6) | 7 (43.8) | 8 (44.4) | 0.62 |
Biochemical relapse | 3 (15.8) | 5 (31.3) | 7 (38.9) | ||
Metastases | 2 (10.5) | 2 (12.5) | 0 | ||
Unknown | 4 (21.1) | 2 (12.5) | 3 (16.7) | ||
FACT-G (total), mean (SD) | 84.2 (17.5) | 85.9 (10.4) | 85.4 (12.3) | 0.93 | |
FACT-P (total), mean (SD) | 118.6 (23.9) | 119.9 (14.5) | 120.4 (17.8) | 0.96 | |
FACT-Fatigue, mean (SD) | 41.0 (10.4) | 39.5 (8.1) | 39.1 (11.0) | 0.84 | |
VO2peak (L/min), mean (SD) | 1.7 (0.4) | 1.9 (0.5) | 1.8 (0.5) | 0.81 | |
Grip strength, mean (SD) | 28.6 (5.7) | 32.6 (8.3) | 33.9 (10.3) | 0.13 | |
Timed chair stands, mean (SD) | 24.5 (7.7) | 24.8 (10.0) | 23.7 (6.3) | 0.90 | |